What you need to know about GB virus C

Sarah L George1, Dino Varmaz

  • 1Division of Infectious Diseases, Saint Louis University School of Medicine, FDT-8N, 3635 Vista Avenue, St. Louis, MO 63110, USA. georgesl@slu.edu

Insights

GB virus C (GBV-C) infection, though nonpathogenic, improves survival in HIV-infected individuals. It achieves this by inhibiting HIV replication and enhancing immune responses, suggesting a protective role.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • GB virus C (GBV-C), a Flaviviridae family member related to Hepatitis C Virus (HCV), is a common, nonpathogenic infection.
  • GBV-C infection persists long-term in both healthy and immunocompromised individuals.
  • Existing research suggests a correlation between GBV-C infection and improved outcomes in HIV-infected individuals.

Purpose of the Study:

  • To investigate the mechanisms by which GBV-C infection influences HIV progression and survival.
  • To explore the potential of GBV-C and its proteins in modulating HIV replication and host immune responses.

Main Methods:

  • Review of existing evidence on GBV-C infection in HIV-positive and HIV-negative populations.
  • Analysis of in vitro studies examining GBV-C's effect on HIV replication and host cell apoptosis.
  • Examination of the role of GBV-C E2 protein in HIV neutralization.

Main Results:

  • GBV-C infection is associated with improved survival, AIDS-free survival, higher CD4(+) T-cell counts, and lower HIV viral loads.
  • In vitro studies demonstrate GBV-C inhibits HIV replication via increased anti-HIV chemokine secretion (MIP-1a, MIP-1b, RANTES, SDF-1, SDF-2) and CCR5 downregulation.
  • GBV-C inhibits host cell apoptosis, and its E2 protein may neutralize HIV in vitro, correlating with prolonged survival in HIV infection.

Conclusions:

  • GBV-C exhibits a protective effect in HIV-infected individuals, potentially through direct inhibition of HIV replication and modulation of immune responses.
  • The nonpathogenic GBV-C may serve as a potential therapeutic target or model for developing strategies against HIV.
  • Further research is warranted to fully elucidate the complex interplay between GBV-C and HIV pathogenesis.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...